(PharmaNewsWire.Com, July 25, 2017 ) Transcatheter aortic valve replacement (TAVR) is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high risk patients. Transcatheter heart valve replacement systems are referred as cardiovascular devices replace the old and damaged valves. TAVR is used for the treatment of aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue).
These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of right chest), and transcaval implantation (through the femoral vein).
North America Transcatheter Aortic Valve Replacement (TAVR) Market: Drivers & Restraints
Increasing number patient population adopting for transcatheter heart valve therapy in the U.S., availability of reimbursement systems for TAVR procedures, growing number of clinical trials for new products by manufacturers, and rising demand for transcatheter heart valve surgery in Canada are driving the growth of transcatheter aortic valve replacement (TAVR) market in North America. However, high cost of the transcatheter aortic valves and certain risks associated with TAVR therapy are expected to restrain the growth of transcatheter aortic valve replacement (TAVR) market in North America.
North America Transcatheter Aortic Valve Replacement (TAVR) Market: Overview
Of these, transfemoral is estimated to command the largest share of North America transcatheter aortic valve replacement (TAVR) market by surgery method in 2016 and expected to grow at the highest CAGR during the forecast period. Based on valve frame material, nitinol segment is expected to account for the largest share of North America transcatheter aortic valve replacement (TAVR) market by valve frame material in 2016.
Transcatheter valve size market is segmented as 14mm to 18mm, 18mm to 22mm, and 22mm to 29mm. Based on valve leaflets material, the market is segmented as bovine heart tissue, cow heart tissue, and other valve leaflets material. Based on end users, the market is sub-segmented as hospitals, ambulatory surgical centres, & cardiac catheterization laboratories. Of these, hospital segment held the largest share of global transcatheter aortic valve replacement (TAVR) market by end users in 2016.
North America Transcatheter Aortic Valve Replacement (TAVR) Market: Region-wise Outlook
On the basis of geographical areas, North America transcatheter aortic valve replacement (TAVR) market is segmented as U.S., and Canada. U.S., accounted for larger share of the North America transcatheter aortic valve replacement (TAVR) market in 2016, whereas Canada is estimated to grow at a higher CAGR during the forecast period 2016-2021.
Key Questions Answered
What will be the market growth till 2021 and what will be the resultant market forecast in the year?
What was the market size from 2016 to 2021 ?
What is the current and future Transcatheter Aortic Valve Replacement (TAVR) Market outlook in North America?
What trends are affecting the North America market?
What is the competitive landscape and market share of major players in the Transcatheter Aortic Valve Replacement (TAVR) space in North America?
What are the key, high growth markets that Transcatheter Aortic Valve Replacement (TAVR) manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Transcatheter Aortic Valve Replacement (TAVR) currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Transcatheter Aortic Valve Replacement (TAVR)?
What are the challenges and barriers that have hindered widespread adoption of Transcatheter Aortic Valve Replacement (TAVR)?
North America Transcatheter Aortic Valve Replacement (TAVR) Market: Key Players
The key players in global transcatheter aortic valve replacement (TAVR) market such as, Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India), and Braile Biomedica (Brazil).
Reasons to buy North America Transcatheter Aortic Valve Replacement (TAVR) Market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
